Mole on Bottom of Foot 2026: ABCDE Guide | Podiatrist

Discovering a dark spot or mole on the bottom of your foot is one of those findings that appropriately gets people’s attention — and in most cases, it turns out to be completely benign. But there is an important subset of foot and ankle skin lesions that represent acral lentiginous melanoma, a form of melanoma that occurs disproportionately on the palms, soles, and nail units, is the most common subtype in people with darker skin, and is routinely diagnosed late because patients and clinicians attribute it to warts, callus, or bruising. Knowing when a dark foot lesion requires evaluation and when it can be safely monitored is knowledge worth having.

Types of Dark Spots on the Bottom of the Foot

Before applying the ABCDE criteria, it’s worth understanding what you’re likely looking at. Most dark spots on the plantar foot (sole) fall into one of several benign categories, with melanoma being far less common but far more consequential.

Plantar warts (verruca plantaris): Caused by human papillomavirus (HPV), plantar warts appear as rough, hyperkeratotic papules that interrupt normal skin lines. The defining feature is pinpoint black dots within the lesion — these are thrombosed capillaries (blood vessels), not pigment. When you pare (shave) the surface of a plantar wart, it bleeds with small punctate bleeding points. They can appear as a single wart or clustered (mosaic pattern).

Benign melanocytic nevi (moles): Benign moles on the sole are relatively uncommon compared to sun-exposed areas but do occur. They are typically uniformly pigmented, symmetric, well-defined, and stable over time. Most people have benign nevi on the sole that remain unchanged throughout their lifetime.

Callus with vascular inclusion (black heel / talon noir): Repetitive trauma causes shearing of dermal capillaries, resulting in hemosiderin deposits within the thickened stratum corneum of a callus. These appear as black or dark brown specks within a callused area — most commonly at the posterior heel of athletes. They are completely benign and resolve as the callus grows out.

Subungual hematoma: Blood collecting under a toenail (from trauma — dropping something, repetitive shoe pressure) appears as black or dark red discoloration under the nail. In athletes, it’s called “runner’s toe.” Most resolve spontaneously as the nail grows out. Distinguish from subungual melanoma by history of trauma and the lesion’s movement with nail growth.

Acral lentiginous melanoma (ALM): The most dangerous lesion in this differential. ALM typically begins as a flat, irregularly pigmented macule on the sole or nail unit, grows slowly over months to years, and is frequently misdiagnosed as a wart or fungal nail until it reaches advanced stages. It does not require sun exposure — UV radiation is not the primary driver of ALM, which is why it occurs at the same rate in people who have never had significant sun exposure.

The ABCDE Rule: How to Assess Any Foot Mole

The ABCDE criteria were developed for all melanoma types but apply well to plantar lesions. Any lesion that meets one or more of these criteria warrants physician evaluation — not watchful waiting at home.

Criterion	What It Means	Benign Pattern	Concerning Pattern
A — Asymmetry	Does one half mirror the other?	Symmetric — both halves match	Asymmetric — one half differs significantly
B — Border	Are the edges well-defined?	Smooth, regular borders	Irregular, notched, or poorly defined
C — Color	Is pigmentation uniform?	Single, uniform brown or tan	Multiple colors — brown, black, red, white, blue
D — Diameter	How large is the lesion?	Smaller than 6mm (pencil eraser)	Larger than 6mm, or growing
E — Evolution	Has it changed?	Stable for years	Growing, changing color, bleeding, or new

Evolution (E) is often the most important criterion for foot lesions. A lesion you’ve had for 20 years without change is far less concerning than a new lesion that appeared in the last 6 months or one that has changed in color, size, or texture. Photo documentation on your phone every few months is a simple monitoring strategy for any ambiguous plantar lesion.

Plantar Wart vs Mole: How to Tell the Difference

Distinguishing plantar warts from melanocytic lesions is clinically important because the treatment approaches diverge dramatically and because aggressive wart treatment on a melanoma delays the diagnosis. Here are the key distinguishing features in our clinical practice:

Skin line disruption: The most reliable clinical clue. The normal ridge-and-furrow pattern of plantar skin (equivalent to fingerprints on the sole) is disrupted by warts — the papillomavirus infiltrates the dermal papillae and interrupts the normal architecture. Moles and melanoma grow within the skin structure without interrupting these lines. Look closely (using a magnifying glass if available) at whether the skin lines pass through or around the lesion.

Pinpoint black dots: The black specks within a plantar wart are thrombosed capillaries — they appear as tiny discrete dots organized along the skin ridge pattern. Melanocytic pigmentation in a mole or ALM appears as diffuse, irregular, or confluent discoloration rather than discrete tiny dots.

Pain with lateral compression vs direct pressure: Warts are characteristically more painful when squeezed from the sides (lateral compression) than when pressed directly. Callus hurts with direct downward pressure. This simple bedside test helps distinguish the two in patients presenting with plantar foot pain.

Multiplicity: Plantar warts are often multiple, clustered, or bilateral. Melanoma typically presents as a single lesion. However, this is not a reliable differentiator — single warts are common, and satellite melanoma lesions do occur.

When in doubt, do not treat empirically. Treating a lesion with wart destructive therapy (salicylic acid, liquid nitrogen) without confirming the diagnosis by clinical examination risks destroying a potentially malignant lesion while creating a delay in diagnosis. In our clinic, any ambiguous pigmented plantar lesion goes to dermatology before treatment.

Black Specks in Callus: What They Mean

Black specks within a plantar callus — sometimes called “talon noir” (French: black heel) or petechiae plantaris — are a common and completely benign finding in athletes and active individuals. They result from shear forces during sport (basketball, tennis, running, soccer) causing rupture of the superficial dermal capillaries. The resulting hemosiderin (blood breakdown product) deposits within the stratum corneum appear as discrete black or dark brown flecks visible through the skin.

These resolve spontaneously as the callus grows out and the superficial layers shed — typically over 4–8 weeks. No treatment is necessary. They can be confirmed clinically by their presence within a heavily keratinized area with a history of athletic activity, their discrete dot morphology (rather than diffuse pigmentation), and their tendency to be more prominent during heavy training periods and less prominent during rest periods.

Acral Lentiginous Melanoma: The Most Serious Concern

Acral lentiginous melanoma (ALM) represents 5% of all melanomas in White patients but 36–72% of melanomas in Black, Hispanic, and Asian patients — a disparity that is largely attributable to delayed diagnosis because the lesions occur in locations that are not routinely skin-checked and in populations where melanoma awareness is lower. The median Breslow thickness at diagnosis for ALM is significantly greater than for other subtypes, directly contributing to worse prognosis.

ALM typically presents as a flat, slowly expanding pigmented macule on the plantar surface — usually the non-weight-bearing areas (heel, arch) rather than the pressure-bearing metatarsal heads. It progresses through a radial growth phase (flat, irregular spreading) before becoming nodular and invasive. The key clinical features are: irregular borders, multiple colors within the same lesion (various shades of brown and black, with possible areas of depigmentation), size typically exceeding 6mm, and gradual growth over months to years.

In our clinic, we have a zero-tolerance policy for ambiguous pigmented plantar lesions in patients who haven’t had a recent dermatology evaluation. When we see anything that doesn’t fit cleanly into the benign categories above — especially in patients with darker skin tones or family history of melanoma — we refer promptly for dermatologic evaluation with dermoscopy and, when indicated, excisional biopsy.

Dark Spots Under the Toenail

Dark discoloration under a toenail is a separate but related concern. The vast majority are subungual hematomas — blood collections from direct trauma that appear dark red to black and move with nail growth over months. The key distinguishing features from subungual melanoma are: history of trauma, the lesion moves distally with nail growth, and it becomes lighter in color as it ages and oxidizes.

Subungual melanoma (a subset of ALM) is less common but presents as dark streaking (melanonychia striata) within the nail that does not move with nail growth, extends from the nail matrix to involve the surrounding skin (Hutchinson’s sign — periungual extension of pigment), and may cause nail dystrophy. The big toenail and thumb nail are the most common sites. Any dark nail streak of sudden onset, irregular width, or with periungual skin involvement warrants biopsy evaluation by a dermatologist.

Who Is at Higher Risk

While conventional melanoma risk factors (fair skin, sun exposure, numerous moles) apply to common subtypes, acral lentiginous melanoma has a distinct risk profile. Higher-risk groups for ALM include: individuals with African, Hispanic, or Asian ancestry (ALM accounts for the majority of melanoma in these groups), patients with a family or personal history of melanoma, patients who are immunocompromised, patients with a large number of moles or a history of atypical nevi anywhere on the body, and individuals over 60 years of age (mean age at ALM diagnosis is approximately 65 years).

Importantly, lack of sun exposure history does NOT reduce risk for ALM. UV radiation is not the primary etiologic driver of ALM, which makes it different from all other melanoma subtypes. Never dismiss a concerning plantar or subungual lesion on the basis that “you’ve never gotten much sun.”

How Physicians Evaluate Foot Lesions

A dermatologist evaluates plantar lesions with dermoscopy — a handheld illuminated magnifying device that visualizes subsurface vascular and pigmentary structures not visible to the naked eye. Dermoscopy can often differentiate wart capillary patterns from melanocytic lesions and identify the parallel ridge pattern of ALM (pigment following the ridges rather than the furrows of plantar skin — the opposite of benign nevi, which follow the furrows).

When a lesion cannot be confidently classified as benign by dermoscopy, excisional biopsy is performed — the entire lesion is removed with a narrow margin (1–2mm) and sent for histopathological examination. This is both diagnostic and potentially curative if the lesion is in situ or thin melanoma. Shave biopsy is generally avoided for suspected melanoma as it may transect the lesion and make Breslow depth measurement unreliable.

Skin Health Products from Our Clinic

Warning Signs That Need Immediate Evaluation

The Most Common Dangerous Mistake

The most dangerous mistake we see with plantar lesions is repeated treatment of a “wart” that never responds to wart therapy. In our clinic, we have seen cases where acral lentiginous melanoma was treated with salicylic acid, liquid nitrogen, and even laser for years before the correct diagnosis was made — simply because the initial clinical impression was “wart” and no one questioned it when the treatment repeatedly failed. A wart that does not respond to at least two appropriate treatment modalities is not a wart until proven otherwise by biopsy.

The fix: if a plantar “wart” has been treated twice without significant improvement, or if the lesion doesn’t have the classic morphology (skin line disruption, pinpoint capillaries), refer for dermatologic evaluation before proceeding with further destructive treatment. In our clinic, we biopsy or refer anything ambiguous rather than applying empirical wart treatment.

In-Office Evaluation at Balance Foot & Ankle

At Balance Foot & Ankle, we evaluate plantar lesions as part of every comprehensive foot examination. For any lesion that raises concern under the ABCDE criteria, or that has been previously treated as a wart without adequate response, Dr. Tom Biernacki coordinates prompt referral to dermatology for dermoscopic evaluation and biopsy when indicated. We do not perform wart treatment on undiagnosed pigmented lesions — diagnosis comes first.

Visit our Howell or Bloomfield Hills location. Learn more about plantar wart treatment at our practice. Call (810) 206-1402 to schedule an evaluation.

In-Office Treatment at Balance Foot & Ankle

If home treatment isn’t providing relief for your foot and ankle conditions, our podiatry team at Balance Foot & Ankle can help with same-day evaluations and advanced in-office care.

Sources

1. Bradford PT, et al. “Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986–2005.” Archives of Dermatology. 2009;145(4):427–434.
2. Phan A, et al. “Dermoscopy of acral melanocytic lesions.” Journal of the American Academy of Dermatology. 2010;62(5):765–773.
3. Bristow IR, et al. “The recognition and diagnosis of acral lentiginous melanoma.” Journal of Foot and Ankle Research. 2010;3(1):10.
4. Luk PP, et al. “Subungual melanoma: diagnosis and management.” Dermatologic Surgery. 2014;40(11):1186–1197.
5. Darmawan CC, et al. “Early detection of acral melanoma: a review of clinical, dermoscopic, and histopathologic features.” Journal of the American Academy of Dermatology. 2019;81(3):805–812.